Copley Scientific Launches Products for Tablet Dissolution Testing
PTSM: Pharmaceutical Technology Sourcing and Management
Copley announced that it has launched new dissolution testing equipment.
On July 7, 2016, Copley Scientific announced that it will be launching new tools for intrinsic dissolution testing. Copley’s Intrinsic Dissolution Kit, which complies with USP Chapter <1087>, includes six or eight 7mm diameter punch and die sets, and a hand-operated, two-ton press for controlled compression of the required compact.
According to Copley, the company has reduced the weight of the new testers by streamlining the physical dimensions of the equipment. The company also offers a slim-line base plate for a range of dissolution testers that minimizes the bench space occupied. The company plans to make similar expansions to its tablet testing equipment.
Source: Copley Scientific
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
